Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive disorders: a repetitive cross-sectional study in 19 European countries.
Publication: The Lancet Regional Health
Shanquan Chena, Tamsin J.Ford, Peter B.Jones, Rudolf N.Cardinal
29 March 2022
Summary
Public data from two surveys (Health Survey for England, UK; Survey of Health, Ageing and Retirement in Europe) covered 19 European countries across EMHAP phases one (2011–2015) and two (2015–2018). People screening positive for depressive symptoms by self-report were included. The primary outcome was antidepressant use: using country-specific weighted regression models, researchers estimated temporal trends and subgroup disparities in antidepressant receipt, with secondary analysis by country-level measures including healthcare expenditure.
